Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep;122(4):760-765.
doi: 10.1002/jso.26060. Epub 2020 Jun 7.

Expandable distal femur megaprosthesis: A European Musculoskeletal Oncology Society study on 299 cases

Eric Lodewijk Staals  1 , Andrea Sambri  2 , Domenico Andrea Campanacci  3 , Francesco Muratori  3 , Andreas Leithner  4 , Magdalena Maria Gilg  4 , Yair Gortzak  5 , Michiel Van De Sande  6 , Edwin Dierselhuis  7 , Eric Mascard  8 , Reinhard Windhager  9 , Philipp Funovics  9 , Martina Schinhan  9 , Oleg Vyrva  10 , Gwen Sys  11 , Nikolay Bolshakov  12 , Will Aston  13 , Panagiotas Gikas  13 , Thomas Schubert  14 , Lee Jeys  15 , Adesegun Abudu  15 , Marco Manfrini  1 , Davide Maria Donati  1
Affiliations

Expandable distal femur megaprosthesis: A European Musculoskeletal Oncology Society study on 299 cases

Eric Lodewijk Staals et al. J Surg Oncol. 2020 Sep.

Abstract

Background and objectives: Expandable distal femur prostheses have become more popular over the last decades, but scientific data is limited.

Methods: A retrospective study was performed, including cases treated between 1986 and 2019 in 15 European referral centers for bone sarcomas.

Results: A total of 299 cases were included. Average follow-up was 80 months (range, 8-287 months). Mean patient age was 10 years. Most (80%) of the implants were noninvasive growers and a fixed hinge knee was used more often (64%) than a rotating hinge. Most prosthetic designs showed good (>80%) implant survival at 10 years, but repeat surgery was required for 63% of the patients. The most frequent reason for revision procedure was the completion of lengthening potential. Noninvasive expandable implants showed less risk of infection compared to invasive growers (11.8% vs 22.9% at 10 years). No difference in aseptic loosening was found between cemented and uncemented stems.

Conclusions: This study shows the increasing popularity of expandable distal femur prostheses, with overall good results for function and implant survival. However, repeat surgery is frequently required, especially in patients under the age of 10 years old. Infection is less frequent in noninvasive growers compared to implants that require invasive lengthening procedures.

Keywords: bone tumor; distal femur; lengthening prosthesis; magnetic; pediatric tumor.

PubMed Disclaimer

References

REFERENCES

    1. Gilg MM, Wibmer C, Bergovec M, Grimer RJ, Leithner A. When do orthopaedic oncologists consider the implantation of expandable prostheses in bone sarcoma patients? Sarcoma. 2018;201:3504075.
    1. Beebe K, Benevenia J, Kaushal N, Uglialoro A, Patel N, Patterson F. Evaluation of a noninvasive expandable prosthesis in musculoskeletal oncology patients for the upper and lower limb. Orthopedics. 2010;33(6):396.
    1. Decilveo AP, Szczech BW, Topfer J, Wittig JC. Reconstruction using expandable endoprostheses for skeletally immature patients with sarcoma. Orthopedics. 2017;40(1):e157-e163.
    1. Eckardt JJ, Kabo JM, Kelley CM, et al. Expandable endoprosthesis reconstruction in skeletally immature patients with tumors. Clin Orthop Relat Res. 2000;373:51-61.
    1. Gilg MM, Gaston CL, Parry MC, et al. What is the morbidity of a non-invasive growing prosthesis? Bone Joint J. 2016;98-B(12):1697-1703.

LinkOut - more resources